It already has a two-drug regimen, Juluca, which was approved in Europe in May, and by the FDA last year. The studies compared the two drug regimen with dolutegravir and a standard “backbone ...

3TC: Lamivudine; ABC: Abacavir; DRV: Darunavir; DTG: Dolutegravir; EFV: Efavirenz; FTC: Emtricitabine; rtv: Ritonavir; TDF: Tenofovir. ↓: Decrease; ↑: Increase ...

The combination of dolutegravir and rilpivirine has been approved as a two-drug pill, marketed under the name Juluca. See Juluca for details of studies that led to its approval and further information ...

One of ViiV Healthcare’s two-drug HIV therapies – Dovato – has been approved in Japan, providing a new treatment option for the country’s 30,000 or so people with HIV. Dovato (dolutegravir ...

During the fourth quarter, GSK and J&J’s Juluca and Dovato contributed around 39% to total HIV sales. While sales of the dolutegravir franchise were down 1% at CER in the U.S. market ...